All News

Community pharmacists help men overcome care avoidance with walk-in screenings, private consults, and outreach.

The major retail entity owns and operates pharmacies across many grocery stores, including Giant, Stop & Shop, Food Lion, and more.

Bryan Wheeler, PharmD, discusses how the Medicare GLP-1 Bridge program works and what it means for independent pharmacy operations.

Direct-to-patient drug programs and telehealth reshape pharmacy, and community pharmacists are an essential component.

Pharmacists leverage CGM and automated insulin delivery to personalize diabetes care, prevent errors, and expand equitable access to technology.

AAP challenges HHS as ACIP stalls, leaving pharmacists and health care in limbo on vaccine coverage and respiratory recommendations.

Precedence Research announces a report regarding growth in the market size and trends of controlled substances in the US.

Pharmacies boost profits by embedding clinical service alerts into dispensing workflows and improving documentation.

This approval provides pharmacists with an option for patients whose levels remain refractory to lifestyle and standard medication.

A drug already used to protect the kidneys may now offer a broader shield.

The pharmacy profession is evolving, and for some pharmacists, that evolution is leading them far beyond the prescription counter and into the world of functional medicine.

Retracted vaccine-autism study exposes statistical flaws, reigniting hepatitis B birth-dose debate and highlighting why pharmacists must rely on evidence-based data.

Independent pharmacies boost margins with business insights and smart automation, shifting from dispensing to sustainable growth.

Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.

Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.

Independent pharmacies can profit from immunizations, boosting loyalty and OTC sales with smart vaccine purchasing and efficient workflows.

Pharmacists guide safe OTC allergy choices and compare Allegra, Claritin, and Zyrtec for fast, 24-hour relief from sneezing and itchy eyes.

The FDA approved Foundayo, which is an oral glucagon-like peptide-1 receptor agonist, for weight loss.

Pharmacists help spot nonresponders, navigate accurate testing, and speed diagnosis.

Patient-centered tools like the Patient's Global Impression of Change scale better assess symptoms, function, quality of life, and treatment effectiveness.

FDA advisors back Moderna’s mRNA flu shot for older adults, hinting at a potential egg-free option for 2026–2027.

The ACTIV-6 trial suggests early metformin may halve clinician-diagnosed long COVID risk, offering a low-cost option pharmacists can apply safely.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

Community pharmacists help prevent chronic wounds with early triage, modern dressing guidance, and diabetic foot care.

Mississippi pharmacy thrives by pioneering medication synchronization, medication packs, and clinical services, cutting chaos and boosting patient care.

The pneumococcal vaccine is approved for protection against 21 serotypes in adults over 18 and children between 2 and 17 at high risk of disease.

Through transformational, authentic, servant, and distributed models, researchers explore the impact of leadership on the pharmacy workforce.

FDA clears first generic Xofluza tablet, bringing affordable single-dose flu treatment and prevention.